-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F4dTjEHYn4R+cl4FiXIf5aRKAntFAvQVI0dGpsUZPyVpVC2xwybvPburoFbpr+QX M85ccjRy6iKdzzWWkTUpXw== 0000919574-99-000696.txt : 19990512 0000919574-99-000696.hdr.sgml : 19990512 ACCESSION NUMBER: 0000919574-99-000696 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990331 FILED AS OF DATE: 19990511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEERFIELD MANAGEMENT CO /NY CENTRAL INDEX KEY: 0001009258 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: 13F-HR SEC ACT: SEC FILE NUMBER: 028-05366 FILM NUMBER: 99616622 BUSINESS ADDRESS: STREET 1: 450 LEXINGTON AVE STREET 2: SUITE 1930 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125511600 MAIL ADDRESS: STREET 1: 450 LEXINGTON AVE SUITE 1930 CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 1999 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Deerfield Management Company Address: 450 Lexington Avenue Suite 1450 New York, New York 10017 Form 13F File Number: 28-5366 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Arnold H. Snider Title: President Phone: (212) 551-1600 Signature, Place, and Date of Signing: /s/ Arnold H. Snider New York, New York May 10, 1999 ________________________ _____________________ ______________ [Signature] [City, State] [Date] Report Type (Check only one.): [X ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manger(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: [If there are no entries in this list, omit this section.] Form 13F File Number Name 28- [Repeat as necessary.] Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 56 Form 13F Information Table Value Total: $651,130 [thousands] List of Other Included Managers: None. Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] No. Form 13F File Number Name 28- [Repeat as necessary.] Form 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 - -------------------- ----------- --------- ------------- ------------- ----------- ---------- ---------------------- TITLE FAIR MARKET SHRS OR INVESTMENT VOTING AUTHORITY NAME OF ISSUER OF CLASS CUSIP VALUE PRN AMT DISCRETION MANAGERS SOLE SHARED NONE - ------------------- --------- --------- ------------ -------------- ----------- ---------- -------- ------ ---- ADAC LABS CS 005313200 6,131,250 450,000 Sole 450,000 APRIA HEALTHCARE GROUP INCG CS 037933108 8,906,250 750,000 Sole 750,000 AMERICAN HOME PRODUCTS COR CS 026609107 26,100,000 400,000 Sole 400,000 BERGEN BRUNSWIG CS 083739102 16,000,000 800,000 Sole 800,000 BAUSCH & LOMB INC CS 071707103 26,000,000 400,000 Sole 400,000 BIORELIANCE CS 090951104 1,332,500 205,000 Sole 205,000 BARR LABS INC CS 068306109 6,100,000 200,000 Sole 200,000 BOSTON SCIENTIFIC CS 101137107 29,453,125 725,000 Sole 725,000 CARDINAL HEALTH INC CS 14149Y108 33,000,000 500,000 Sole 500,000 CEPHALON INC CS 156708109 3,500,000 400,000 Sole 400,000 COLLAGEN AESTHETIC CS 194194106 3,359,375 250,000 Sole 250,000 CENTOCOR CS 152324101 22,162,500 600,000 Sole 600,000 COVANCE INC CS 222816100 15,037,500 600,000 Sole 600,000 COUNSEL CORP CS 22226R102 2,650,000 400,000 Sole 400,000 C.R. BARD CS 067383109 27,740,625 550,000 Sole 550,000 CYGNUS CS 232564101 8,700,000 1,160,000 Sole 1,160,000 DENTSPLY INTL INC. CS 249030107 9,881,250 425,000 Sole 425,000 DURA pHARMACEUTICAL INC CS 26632S109 12,006,250 850,000 Sole 850,000 ENTREMED INC CS 29382F103 11,084,288 524,700 Sole 524,700 ENZON INC CS 293904108 1,327,500 90,000 Sole 90,000 ENDOSONICS CORP CS 29264K108 1,950,000 300,000 Sole 300,000 FISHER IMAGING CORP CS 337719108 525,000 400,000 Sole 400,000 FOREST LABS INC. CS 345838106 36,643,750 650,000 Sole 650,000 GUILFORD PHARMACEUTICAL CS 401829106 6,825,000 600,000 Sole 600,000 GENETECH INC CS 368710307 8,862,500 100,000 Sole 100,000 GENSIA INC. CS 372450106 196,875 70,000 Sole 70,000 HEALTHSOUTH CORP CS 421924101 5,187,500 500,000 Sole 500,000 HEALTH SYSTEMS DESIGN CS 421964107 470,000 80,000 Sole 80,000 IMMUNEX CS 452528102 31,468,500 378,000 Sole 378,000 INCYTE PHARMACEUTICALS CS 45337c102 10,532,8130 525,000 Sole 525,000 KENDLE INTL CS 48880L107 6,037,500 300,000 Sole 300,000 LIGAND PHARM CS 53220K108 4,912,500 600,000 Sole 600,000 MAXXIM MEDICAL CS 57777G105 5,662,500 300,000 Sole 300,000 MAGELLAN HEALTH SERVICES CS 559079108 956,006 228,300 Sole 228,300 MERCK & CO CS 589331107 48,075,000 600,000 Sole 600,000 NABI INC CS 628716102 7,515,625 2,405,000 Sole 2,405,000 NOVOSTE CORP CS 67010C100 12,000,000 500,000 Sole 500,000 NEOPATH INC CS 640517108 2,400,000 600,000 Sole 600,000 OWENS & MINOR INC CS 690732102 4,050,000 400,000 Sole 400,000 PERCLOSE INC. CS 71361C107 18,600,000 600,000 Sole 600,000 PHYCOR INC CS 71940F100 7,018,125 1,477,500 Sole 1,477,500 PAREXEL INTL CORP CS 699462107 7,240,625 350,000 Sole 350,000 QUORUM HEALTH GROUP CS 749084109 750,000 75,000 Sole 75,000 QLT PHOTOTHERAPEUTICS CS 746927102 36,675,000 900,000 Sole 900,000 QUEST DIAGNOSTICS CS 74834L100 3,827,000 172,000 Sole 172,000 RESPIRONICS INC. CS 761230101 9,231,250 700,000 Sole 700,000 ROBERTS PHARMACEUTICAL CS 770491108 12,450,000 600,000 Sole 600,000 SYNCOR INTL. CS 87157J106 8,362,500 300,000 Sole 300,000 SEROLOGICALS CORP CS 817523103 6,103,125 450,000 Sole 450,000 SHIRE PHARMACEUTICAL GROUP CS 82481R106 8,896,875 390,000 Sole 390,000 SYNETIC INC. CS 87160F109 2,346,750 42,000 Sole 42,000 TEVA PHARMACEUTICAL GROUP CS 881624209 16,603,125 350,000 Sole 350,000 TOTAL RENAL CARE CS 89151S107 11,000,000 1,000,000 Sole 1,000,000 WARNER LAMBERT COMPANY CS 934488107 26,500,000 400,000 Sole 400,000 WATSON PHARMACEUTICALS CS 942683103 9,707,500 220,000 Sole 220,000 ZONAGEN INC CS 98975L108 1,075,000 50,000 Sole 50,000 Total 651,130,356
[Repeat as necessary] 00871001.AQ3 -----END PRIVACY-ENHANCED MESSAGE-----